Concepedia

Antony Sabin

AS

6

Publications

390

Citations

6

H-Index

2001

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Antony Sabin is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2001–2021

6

Publications

6

A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA

T. K. Jha, Shyam Sundar, Chandreshwar Prasad Thakur et al. · American Journal of Tropical Medicine and Hygiene · 2005 · 137 citations · Full text

, , +9

A PHASE II DOSE-INCREASING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA

MONIQUE K. WASUNNA, JUMA R. RASHID, JANE MBUI et al. · American Journal of Tropical Medicine and Hygiene · 2005 · 86 citations · Full text

, , +9

TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer

Charles S. Fuchs, Marwan Fakih, Lee S. Schwartzberg et al. · Cancer · 2013 · 65 citations · Full text

Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine

Eliane Fuseau, Olivier Pétricoul, Antony Sabin et al. · Clinical Therapeutics · 2001 · 41 citations

, , +5

Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis

Khader Shameer, Youyi Zhang, Dan Jackson et al. · Frontiers in Oncology · 2021 · 34 citations · Full text

Rows per page

1–5 of 6